SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
Loading market information…
SHH · 688321.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shenzhen Chipscreen Biosciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.54% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shenzhen Chipscreen Biosciences Co., Ltd.’s next earnings report is currently expected on Mar 31, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shenzhen Chipscreen Biosciences Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2001 and headquartered in Shenzhen, China, Chipscreen Biosciences specializes in the discovery, development, and commercialization of innovative small-molecule pharmaceuticals. The company cultivates a pipeline of novel drug candidates and precursor compounds, all of which are progressing through diverse research phases and are protected by extensive global intellectual property rights. Its key therapeutic areas of focus encompass oncology, metabolic disorders, and autoimmune conditions.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| CN¥176.83M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
HK$50.90+HK$0.25 (+0.49%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.12% below the high.
CN¥81.00-CN¥2.03 (-2.44%)
Shanghai Allist Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.43% below the high.
CN¥18.80-CN¥0.10 (-0.53%)
Chengdu Kanghong Pharmaceutical Group Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.13% below the high.
CN¥40.10+CN¥0.06 (+0.15%)
Betta Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.71% below the high.
CN¥33.75-CN¥1.78 (-5.01%)
Evopoint Biosciences Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.27% below the high.
CN¥34.70-CN¥0.69 (-1.95%)
Shanghai Yizhong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.58% below the high.
